386 related articles for article (PubMed ID: 8432600)
1. Toxicity of recombinant toxic shock syndrome toxin 1 and mutant toxins produced by Staphylococcus aureus in a rabbit infection model of toxic shock syndrome.
Bonventre PF; Heeg H; Cullen C; Lian CJ
Infect Immun; 1993 Mar; 61(3):793-9. PubMed ID: 8432600
[TBL] [Abstract][Full Text] [Related]
2. A mutation at histidine residue 135 of toxic shock syndrome toxin yields an immunogenic protein with minimal toxicity.
Bonventre PF; Heeg H; Edwards CK; Cullen CM
Infect Immun; 1995 Feb; 63(2):509-15. PubMed ID: 7822015
[TBL] [Abstract][Full Text] [Related]
3. Immunobiologic and biochemical properties of mutants of toxic shock syndrome toxin-1.
Murray DL; Prasad GS; Earhart CA; Leonard BA; Kreiswirth BN; Novick RP; Ohlendorf DH; Schlievert PM
J Immunol; 1994 Jan; 152(1):87-95. PubMed ID: 8254210
[TBL] [Abstract][Full Text] [Related]
4. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection.
Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S
mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722
[TBL] [Abstract][Full Text] [Related]
5. Mutants of staphylococcal toxic shock syndrome toxin 1: mitogenicity and recognition by a neutralizing monoclonal antibody.
Blanco L; Choi EM; Connolly K; Thompson MR; Bonventre PF
Infect Immun; 1990 Sep; 58(9):3020-8. PubMed ID: 1696937
[TBL] [Abstract][Full Text] [Related]
6. Fluid replacement protection of rabbits challenged subcutaneous with toxic shock syndrome toxins.
Lee PK; Deringer JR; Kreiswirth BN; Novick RP; Schlievert PM
Infect Immun; 1991 Mar; 59(3):879-84. PubMed ID: 1997438
[TBL] [Abstract][Full Text] [Related]
7. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
Asano K; Narita K; Hirose S; Nakane A
Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
[TBL] [Abstract][Full Text] [Related]
8. Passive protection of rabbits infected with toxic shock syndrome-associated strains of Staphylococcus aureus by monoclonal antibody to toxic shock syndrome toxin 1.
Scott DF; Best GK; Kling JM; Thompson MR; Adinolfi LE; Bonventre PF
Rev Infect Dis; 1989; 11 Suppl 1():S214-7; discussion S217-8. PubMed ID: 2928638
[TBL] [Abstract][Full Text] [Related]
9. Role of a carboxy-terminal site of toxic shock syndrome toxin 1 in eliciting immune responses of human peripheral blood mononuclear cells.
Drynda A; König B; Bonventre PF; König W
Infect Immun; 1995 Mar; 63(3):1095-101. PubMed ID: 7532624
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with plasmid DNA encoding a mutant toxic shock syndrome toxin-1 ameliorates toxin-induced lethal shock in mice.
Feng MH; Cui JC; Nakane A; Hu DL
Tohoku J Exp Med; 2013 Sep; 231(1):1-8. PubMed ID: 23985881
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies of toxic shock toxin-1-secreting Staphylococcus aureus and implications for burn care in children.
Laabei M; Young A; Jenkins TA
Pediatr Infect Dis J; 2012 May; 31(5):e73-7. PubMed ID: 22301473
[TBL] [Abstract][Full Text] [Related]
12. Affinity purification of staphylococcal toxic shock syndrome toxin 1 and its pathologic effects in rabbits.
Reeves MW; Arko RJ; Chandler FW; Bridges NB
Infect Immun; 1986 Feb; 51(2):431-9. PubMed ID: 3943896
[TBL] [Abstract][Full Text] [Related]
13. Acquired ability of Staphylococcus aureus to produce toxic shock-associated protein and resulting illness in a rabbit model.
Rasheed JK; Arko RJ; Feeley JC; Chandler FW; Thornsberry C; Gibson RJ; Cohen ML; Jeffries CD; Broome CV
Infect Immun; 1985 Mar; 47(3):598-604. PubMed ID: 3156093
[TBL] [Abstract][Full Text] [Related]
14. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses.
Spaulding AR; Lin YC; Merriman JA; Brosnahan AJ; Peterson ML; Schlievert PM
Vaccine; 2012 Jul; 30(34):5099-109. PubMed ID: 22691432
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus isolates from patients with nonmenstrual toxic shock syndrome. Evidence for additional toxins.
Garbe PL; Arko RJ; Reingold AL; Graves LM; Hayes PS; Hightower AW; Chandler FW; Broome CV
JAMA; 1985 May; 253(17):2538-42. PubMed ID: 3981783
[TBL] [Abstract][Full Text] [Related]
16. Double mutant and formaldehyde inactivated TSST-1 as vaccine candidates for TSST-1-induced toxic shock syndrome.
Gampfer J; Thon V; Gulle H; Wolf HM; Eibl MM
Vaccine; 2002 Jan; 20(9-10):1354-64. PubMed ID: 11818153
[TBL] [Abstract][Full Text] [Related]
17. Distribution and expression of toxic shock syndrome toxin 1 gene among Staphylococcus aureus isolates of toxic shock syndrome and non-toxic shock syndrome origin.
Bonventre PF; Weckbach L; Harth G; Haidaris C
Rev Infect Dis; 1989; 11 Suppl 1():S90-5. PubMed ID: 2928656
[TBL] [Abstract][Full Text] [Related]
18. Effect of chemical modification of histidine and tyrosine residues in toxic shock syndrome toxin 1 on the serologic and mitogenic activities of the toxin.
Kokan-Moore NP; Bergdoll MS
Infect Immun; 1989 Jul; 57(7):1901-5. PubMed ID: 2499540
[TBL] [Abstract][Full Text] [Related]
19. [Neutralizing activity of human immunoglobulin preparation against toxic shock syndrome toxin-1].
Nakae T; Hirayama F; Hashimoto M
Kansenshogaku Zasshi; 2002 Mar; 76(3):195-202. PubMed ID: 11974889
[TBL] [Abstract][Full Text] [Related]
20. Immunological protection of rabbits infected with Staphylococcus aureus isolates from patients with toxic shock syndrome.
Scott DF; Kling JM; Best GK
Infect Immun; 1986 Aug; 53(2):441-4. PubMed ID: 3733224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
